Drug Profile
Oncolytic adenovirus gene therapy - Multivir
Alternative Names: Ad-VirRx 007; Ad-VirRx 007 -MultiVir; Ad5-VirRx 007Latest Information Update: 28 May 2019
Price :
$50
*
At a glance
- Originator MultiVir
- Class Antineoplastics; Gene therapies; Oncolytic viruses
- Mechanism of Action Apoptosis regulatory protein stimulants; Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 28 May 2019 No recent reports of development identified for phase-I development in Solid-tumours in USA (Parenteral)
- 18 Apr 2016 Phase-I clinical trials in Solid tumours in USA (Parenteral)